The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Impact of adjuvant therapy in lymph-node positive vulvar cancer: The AGO CARE 1 study.
Sven Mahner
No relevant relationships to disclose
Julia Kathrin Jueckstock
No relevant relationships to disclose
Felix Hilpert
No relevant relationships to disclose
Dirk Lubbe
No relevant relationships to disclose
Philipp Harter
No relevant relationships to disclose
Nikolaus De Gregorio
No relevant relationships to disclose
Severine Iborra
No relevant relationships to disclose
Frank Chen
No relevant relationships to disclose
Adela Stoenescu
No relevant relationships to disclose
Peter Hillemanns
No relevant relationships to disclose
Sophie Fuerst
No relevant relationships to disclose
Hans-Georg Strauss
No relevant relationships to disclose
Klaus H. Baumann
No relevant relationships to disclose
Falk Thiel
No relevant relationships to disclose
Alexander Mustea
No relevant relationships to disclose
Werner Meier
No relevant relationships to disclose
Andreas Du Bois
No relevant relationships to disclose
Pauline Wimberger
No relevant relationships to disclose
Lis-Femke Griebel
No relevant relationships to disclose
Linn Lena Woelber
No relevant relationships to disclose